Transcarent
Denver, US · 14 known investors
Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care. It is sold to employers as a benefit to address healthcare cost, complexity, and access for their members.
Investors · 14
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$126M disclosed across 1 round · 2024
- $126MSeries DMay 2024 · 2 sources
7wireVentures (lead), General Catalyst (lead), Ally Bridge Group, Alta Partners, Geodesic Capital, Human Capital, Kinnevik, Leaps by Bayer, Memorial Hermann Health System, Merck Global Health Innovation Fund, Threshold Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Transcarent went on to found or lead other companies.
Competitors · 3
by search overlapCompanies competing with Transcarent for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Transcarent do?
- Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care. It is sold to employers as a benefit to address healthcare cost, complexity, and access for their members.
- Who are Transcarent's investors?
- Transcarent's investors include 7wire Ventures, Corewell Health Ventures, General Catalyst, Geodesic Capital, GreatPoint Ventures, Human Capital, Kinnevik, Ally Bridge Group and 4 more.
- How much funding has Transcarent raised?
- Transcarent has disclosed $126M raised across 1 round.
- Where is Transcarent headquartered?
- Transcarent is headquartered in Denver, US.
.png)




